SUSQUEHANNA INTERNATIONAL GROUP, LLP - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 43 filers reported holding APREA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$50,574
-51.8%
157,965
-2.6%
0.00%
Q3 2022$105,000
-26.1%
162,262
-15.3%
0.00%
Q2 2022$142,000
-69.1%
191,657
-22.3%
0.00%
Q1 2022$460,000
-35.0%
246,769
-0.0%
0.00%
Q4 2021$708,000
-58.4%
246,778
-25.9%
0.00%
Q3 2021$1,702,000
+86.4%
333,153
+78.0%
0.00%
Q2 2021$913,000
+332.7%
187,161
+354.3%
0.00%
Q1 2021$211,00041,2000.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders